• Je něco špatně v tomto záznamu ?

Vyšetření viability před revaskularizací?
[Effect of revascularization on long-term survival in patients with ischemic left ventricular dysfunction and a wide range of viability]

Sawada SG, et al.

. 2010 ; 4 (6) : 42.

Jazyk čeština Země Česko

Typ dokumentu srovnávací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc10036370

Short-term survival in patients with viability and ischemic left ventricular dysfunction appears improved by revascularization, but no randomized studies have shown a long-term benefit of revascularization in patients with a wide range of viability. Propensity analysis was used as a substitute for randomization in a study comparing the survival of revascularized and medically treated patients with ischemic dysfunction. Dobutamine echocardiography was performed in 274 patients with ischemic left ventricular dysfunction (mean ejection fraction 32%), with 32% having viability in > or =25% of the myocardium. Clinical, angiographic, and echocardiographic characteristics were comparable between treatment groups except for multivessel disease, hyperlipidemia, and the percentage of nonviable myocardium. A propensity score, reflecting the probability of receiving revascularization, was derived for each patient from baseline variables. After stratification by propensity scores, there were no differences between groups. Patients were followed for cardiac death. Revascularization was performed in 130 patients, and 144 were medically treated. There were 114 cardiac deaths (42%) over 4.5 years of follow-up. After propensity score adjustment, survival was better with revascularization (mean survival 5.9 vs 3.3 years, hazard ratio 0.42, 95% confidence interval 027 to 0.65, p <0.0001). Medical and device therapy during follow-up was similar between treatment groups, except that beta-blocker use was more common in revascularized patients. After adjustment for beta-blocker use and propensity score, survival remained better in revascularized patients (hazard ratio 0.47, 95% confidence interval 0.30 to 0.72, p = 0.0006). In conclusion, revascularization improves long-term survival in patients with ischemic left ventricular dysfunction and a wide range of viability.

Effect of revascularization on long-term survival in patients with ischemic left ventricular dysfunction and a wide range of viability

Recenze v:

Komentář [k článku Vyšetření viability před revaskularizací?].

000      
00000naa 2200000 a 4500
001      
bmc10036370
003      
CZ-PrNML
005      
20111210200849.0
008      
110111s2010 xr e cze||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a cze $b eng
044    __
$a xr
100    1_
$a Sawada, S. G.
245    10
$a Vyšetření viability před revaskularizací? / $c Sawada SG, et al.
246    11
$a Effect of revascularization on long-term survival in patients with ischemic left ventricular dysfunction and a wide range of viability
314    __
$a Krannert Institute of Cardiology, Department of Medicine, Indiana University Medical Center, Indianapolis ssawada@iupui.edu
520    9_
$a Short-term survival in patients with viability and ischemic left ventricular dysfunction appears improved by revascularization, but no randomized studies have shown a long-term benefit of revascularization in patients with a wide range of viability. Propensity analysis was used as a substitute for randomization in a study comparing the survival of revascularized and medically treated patients with ischemic dysfunction. Dobutamine echocardiography was performed in 274 patients with ischemic left ventricular dysfunction (mean ejection fraction 32%), with 32% having viability in > or =25% of the myocardium. Clinical, angiographic, and echocardiographic characteristics were comparable between treatment groups except for multivessel disease, hyperlipidemia, and the percentage of nonviable myocardium. A propensity score, reflecting the probability of receiving revascularization, was derived for each patient from baseline variables. After stratification by propensity scores, there were no differences between groups. Patients were followed for cardiac death. Revascularization was performed in 130 patients, and 144 were medically treated. There were 114 cardiac deaths (42%) over 4.5 years of follow-up. After propensity score adjustment, survival was better with revascularization (mean survival 5.9 vs 3.3 years, hazard ratio 0.42, 95% confidence interval 027 to 0.65, p <0.0001). Medical and device therapy during follow-up was similar between treatment groups, except that beta-blocker use was more common in revascularized patients. After adjustment for beta-blocker use and propensity score, survival remained better in revascularized patients (hazard ratio 0.47, 95% confidence interval 0.30 to 0.72, p = 0.0006). In conclusion, revascularization improves long-term survival in patients with ischemic left ventricular dysfunction and a wide range of viability.
650    _2
$a senioři $7 D000368
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a ischemická choroba srdeční $x terapie $7 D017202
650    _2
$a revaskularizace myokardu $7 D009204
650    _2
$a míra přežití $7 D015996
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
650    _2
$a dysfunkce levé srdeční komory $x terapie $7 D018487
655    _2
$a srovnávací studie $7 D003160
773    0_
$w MED00012706 $t Clinical cardiology alert $g Roč. 4, č. 6 (2010), s. 42 $x 1213-2586
787    18
$w bmc10036371 $i Recenze v: $t Komentář [k článku Vyšetření viability před revaskularizací?]
910    __
$a ABA008 $b B 2242 $c 407 a $y 7
990    __
$a 20110106080203 $b ABA008
991    __
$a 20110128161318 $b ABA008
999    __
$a ok $b bmc $g 825182 $s 690292
BAS    __
$a 3
BMC    __
$a 2010 $b 4 $c 6 $d 42 $m Clinical Cardiology Alert $x MED00012706
LZP    __
$a 2011-01/mkme

Najít záznam